Michael Schupp

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. ncbi Endogenous ligands for nuclear receptors: digging deeper
    Michael Schupp
    Department of Endocrinology, Diabetes, and Nutrition and Center for Cardiovascular Research, Institute of Pharmacology, Charite University Medicine Berlin, 10115 Berlin, Germany
    J Biol Chem 285:40409-15. 2010
  2. ncbi Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation
    Jurgen Janke
    Medical Faculty of the Charite, Franz Volhard Clinic, HELIOS Klinikum Berlin, Berlin, Germany
    J Hypertens 24:1809-16. 2006
  3. ncbi Telmisartan: from lowering blood pressure to end-organ protection
    Thomas Unger
    Charite University Medicine Berlin, Center for Cardiovascular Research CCR Institute of Pharmacology and Toxicology Hessische Strasse 3 4, 10115 Berlin, Germany
    Future Cardiol 1:7-15. 2005
  4. ncbi Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan
    Markus Clemenz
    Center for Cardiovascular Research, Institute of Pharmacology, Charite Universitatsmedizin Berlin, Hessische Str 3 4, 10115 Berlin, Germany
    Diabetes 57:1405-13. 2008

Collaborators

Detail Information

Publications4

  1. ncbi Endogenous ligands for nuclear receptors: digging deeper
    Michael Schupp
    Department of Endocrinology, Diabetes, and Nutrition and Center for Cardiovascular Research, Institute of Pharmacology, Charite University Medicine Berlin, 10115 Berlin, Germany
    J Biol Chem 285:40409-15. 2010
    ..This knowledge about the nature and physiology of these ligands may create new opportunities for therapeutic drug development...
  2. ncbi Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation
    Jurgen Janke
    Medical Faculty of the Charite, Franz Volhard Clinic, HELIOS Klinikum Berlin, Berlin, Germany
    J Hypertens 24:1809-16. 2006
    ..In clonal animal cells, certain angiotensin receptor blockers (ARB) activate the peroxisome proliferator-activated receptor-gamma (PPARgamma). The aim of this work was to validate that observation in human cells and humans...
  3. ncbi Telmisartan: from lowering blood pressure to end-organ protection
    Thomas Unger
    Charite University Medicine Berlin, Center for Cardiovascular Research CCR Institute of Pharmacology and Toxicology Hessische Strasse 3 4, 10115 Berlin, Germany
    Future Cardiol 1:7-15. 2005
    ..Due to its long duration of action, it compares favorably with other angiotensin receptor blockers. Latest data from clinical trials and newest research regarding telmisartan will be reviewed in this article...
  4. ncbi Liver-specific peroxisome proliferator-activated receptor alpha target gene regulation by the angiotensin type 1 receptor blocker telmisartan
    Markus Clemenz
    Center for Cardiovascular Research, Institute of Pharmacology, Charite Universitatsmedizin Berlin, Hessische Str 3 4, 10115 Berlin, Germany
    Diabetes 57:1405-13. 2008
    ..Activation of the PPARalpha ligand binding domain (LBD) was investigated using transactivation assays...